Literature DB >> 17610781

Thrombolytic therapy for acute ischemic stroke - Tissue plasminogen activator for acute ischemic stroke: Is the CAEP Position Statement too negative?

J R Hoffman1.   

Abstract

Entities:  

Year:  2001        PMID: 17610781     DOI: 10.1017/s1481803500005510

Source DB:  PubMed          Journal:  CJEM        ISSN: 1481-8035            Impact factor:   2.410


× No keyword cloud information.
  5 in total

1.  Truths about the NINDS study: setting the record straight.

Authors:  Jeffrey Mann
Journal:  West J Med       Date:  2002-05

2.  Why don't more patients receive intravenous rt-PA for acute stroke?

Authors:  Patrick Lyden
Journal:  Expert Rev Neurother       Date:  2015-05-04       Impact factor: 4.618

3.  Intra-arterial versus intra-venous thrombolysis within and after the first 3 hours of stroke onset.

Authors:  Srivastava Padma; Moonis Majaz
Journal:  Arch Med Sci       Date:  2010-06-30       Impact factor: 3.318

4.  A user's guide to the NINDS rt-PA stroke trial database.

Authors:  Robert J Dachs; John H Burton; Jeremy Joslin
Journal:  PLoS Med       Date:  2008-05-20       Impact factor: 11.069

Review 5.  Making trials matter: pragmatic and explanatory trials and the problem of applicability.

Authors:  Shaun Treweek; Merrick Zwarenstein
Journal:  Trials       Date:  2009-06-03       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.